SynthesisG3 (Bethesda, Md.)2026
Brain transcriptome-wide association studies in diverse ancestral populations reveal genes implicated in an anxiety-related phenotype.
Synthesis in G3 (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Anxiety is the most prevalent form of mental illness in the United States. We aimed to identify genetic variation underlying anxiety in diverse ancestral populations through integrating genomic and brain transcriptomic data. We analyzed genome-wide association study (GWAS) summary statistics, using the "Worrier/Anxious Feelings" phenotype from Pan-UK Biobank. We identified 67 independent significant loci in the combined meta-analysis of six ancestral populations (META-GWAS) and 1 locus in the African (AFR) GWAS (P < 5.0 × 10-8). We performed transcriptome-wide association studies (TWAS) and identified 683 significantly associated genes in the META-TWAS, and 1 gene in the AFR-TWAS (P < 3.85 × 10-6). Namely, we identified CADM2 in the META-TWAS and its predicted paralog SMAGP in the AFR-TWAS. The genes identified in TWAS were enriched for variants associated with autism, neuroticism, and schizophrenia, highlighting shared genetic architecture among neuropsychiatric traits. In this study, we present these loci and genes as potential targets for future research on anxiety-related phenotypes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.